Still, the observation that the CHK2 variants aggregated with enhanced propensity into amyloid-like fibrils in vitro, displaying high expression in tumor samples, could be related to dominant-negative effects, whereby the WT protein is prevented from carrying out its function by binding to the variant protein, leading to its accumulation and consequent disproportionate loss of function. The gene discussed is CHEK2; the disease is neoplasm.